Document Title: Outcome of Board Meeting - Management Appointments and Committee Re-constitution
Summary of Key Information:
Reporting Period (Quarter/Year): Not Applicable
Nature of Filing / Announcement: Outcome of Board Meeting pursuant to Regulation 30 of SEBI Listing Regulations
Date of Board Meeting / Approval: June 26, 2026
Audit Opinion: Not Specified
Auditor's Comment: Not Specified
Key Financial Highlights: Not Specified
Standalone Results: Not Specified
Consolidated Results: Not Specified
Segment-wise Performance: Not Specified
Corporate Actions:
Not Specified
Regulatory Disclosures:
A. Appointment of Mr. Himanshu Agarwal as Chief Financial Officer and Director
- Mr. Himanshu Agarwal (DIN: 06672915) appointed as Chief Financial Officer (Key Managerial Personnel) and Additional Director
- To be designated as Whole-time Director and Chief Financial Officer effective September 17, 2026
- Appointment as Whole-time Director is for a term of 5 consecutive years from September 17, 2026 to September 16, 2031
- Appointment is subject to approval of shareholders and other applicable statutory approvals
- Company will intimate stock exchanges upon Mr. Agarwal assuming office
- Mr. Agarwal is not related to any Directors of the Company and is not debarred from holding director office by SEBI or any other authority
- Mr. Agarwal has over three decades of experience in finance leadership, corporate governance, mergers and acquisitions, and business transformation across listed organisations in India and internationally
- Previous positions include senior finance roles at ICI India Limited, AstraZeneca Pharma India Limited, AkzoNobel India Limited (as Whole Time Director), Huhtamaki Oyj (Flexible Packaging Division), Bennett, Coleman and Co. Limited (Times Group)
- Currently serving as Whole Time Director and Chief Financial Officer of Cohance Lifesciences Limited
- Recognized with Best CFO Award by Institute of Chartered Accountants of India and among Top 100 India CFOs by CFO Institute
- Qualified Chartered Accountant, Company Secretary and Cost and Management Accountant
B. Re-constitution of the Committees of the Board of Directors
- Board approved re-constitution of certain Committees effective June 27, 2026
- Changes facilitate smooth transition and ensure continuity in committee functioning
- Transition necessary due to completion of Mr. Ashish Gupta's term as Independent Director on July 20, 2026
Audit Committee Composition (effective June 27, 2026):
- Mr. Sanjiv Sachar (Independent Director) - Chairman
- Mr. Ashish Gupta (Independent Director) - Member
- Ms. Geeta Mathur (Independent Director) - Member
- Ms. Radha Rajappa (Additional Director, Independent Category) - Member (newly inducted)
Nomination & Remuneration Committee Composition:
- Mr. Ashish Gupta (Independent Director) - Chairman & Member till July 20, 2026
- Mr. Kapil Kapoor (Non-Executive Director) - Member
- Mr. Sanjiv Sachar (Independent Director) - Member
- Mr. Rajesh Magow (Additional Director, Independent Category) - Member with effect from June 27, 2026 and Chairman with effect from July 21, 2026
Meeting Details:
- Board Meeting commenced at 07:34 p.m. and concluded at 07:55 p.m. on June 26, 2026
Additional Information:
- Intimation uploaded on Company's website at www.infoedge.in
- Signed by Jaya Bhatia, Company Secretary & Compliance Officer